Champions Oncology

Yahoo Finance • 5 days ago

Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge

On February 17, 2026, Battery Management Corp. disclosed an increase of 839,864 shares in Braze(NASDAQ:BRZE), an estimated $24.88 million trade based on quarterly average pricing. What happened According to a February 17, 2026, SEC filin... Full story

Yahoo Finance • 5 days ago

Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year

As of December 31, 2025, Battery Management Corp. disclosed in a U.S. Securities and Exchange Commission filing that it sold out its entire Zeta Global Holdings Corp.(NYSE:ZETA) stake, an estimated $9.05 million transaction. What happened... Full story

Yahoo Finance • 5 days ago

Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know

On February 17, 2026, Battery Management Corp. disclosed a new position, acquiring 11,356,669 shares in Kodiak AI(NASDAQ:KDK) for an estimated $124.01 million. What happened According to a SEC filing dated February 17, 2026, Battery Mana... Full story

Yahoo Finance • 5 days ago

Sprinklr Stock Down 40% in a Year as One Fund Sells Nearly $3 Million Worth of Shares

On February 17, 2026, Battery Management disclosed in a U.S. Securities and Exchange Commission (SEC) filing that it sold 374,479 shares of Sprinklr(NYSE:CXM), an estimated $2.85 million trade based on quarterly average pricing. What happ... Full story

Yahoo Finance • 5 months ago

Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss

Champions Oncology Inc (NASDAQ:CSBR [https://www.chartmill.com/stock/quote/CSBR]) reported its first-quarter fiscal 2026 earnings, posting record quarterly revenue of $14.0 million but falling short of profitability expectations. The trans... Full story

Yahoo Finance • 7 months ago

Champions Oncology earnings missed by $0.13, revenue fell short of estimates

Investing.com - Champions Oncology (NASDAQ: CSBR) reported first quarter EPS of $-0.070, $0.13 worse than the analyst estimate of $0.060. Revenue for the quarter came in at $12.36M versus the consensus estimate of $15.7M. Champions Onco... Full story